Periodontal Disease Linked to Diabetes and Heart Disease

Periodontitis and health risks

The inflammatory response of the periodontal infection cascade is not limited to the peridontium. The red complex bacteria, and other products of infection, can enter the bloodstream. In response, the body produces C-reactive protein, which has been associated with a variety of cardiovascular events, such as heart disease and stroke. There may be a link between periodontal disease and:

  • Diabetes
  • Heart disease
  • Stroke
  • Preterm, low-birthweight baby

Are we doing enough to treat this common, chronic infection of the periodontal foundation? Learn about the need for comprehensive periodontitis treatment.

Video not available

P. DiGangi, RDH, BS
Addison, IL

View All Videos In Library »

ARESTIN® is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. ARESTIN® may be used as part of a periodontal maintenance program, which includes good oral hygiene and SRP.

IMPORTANT SAFETY INFORMATION

ARESTIN® should not be used in any patient who has a known sensitivity to minocycline or tetracyclines. The use of drugs of the tetracycline class during tooth development may cause permanent discoloration of the teeth, and therefore should not be used in children or in pregnant or nursing women. Hypersensitivity reactions that included, but were not limited to, anaphylaxis, angioneurotic edema, urticaria, rash, swelling of the face and pruritus have been reported with the use of ARESTIN®. In clinical trials, the most frequently reported nondental treatment-emergent adverse events were headache, infection, flu syndrome and pain.

Please see Full Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Contact us with questions about your account or MyArestin.com